Flora Peyvandi: Intrinsic Thrombin Generation in Severe Hemophilia A
Flora Peyvandi, Professor of Internal Medicine at the University of Milan and former President of ISTH, shared a post on X about a recent article by Emma H. Urlings et al. published in Research and Practice in Thrombosis and Haemostasis, adding:
”Intrinsic Activated Thrombin Generation for Treatment Efficacy and Monitoring of Octocog Alpha and Emicizumab in Severe Hemophilia A – Research and Practice in Thrombosis and Haemostasis”
Title: Intrinsic Activated Thrombin Generation for Treatment Efficacy and Monitoring of Octocog Alpha and Emicizumab in Severe Hemophilia A
Authors: Emma H. Urlings, Floor C.J.I. Heubel-Moenen, René van Oerle, Dave L.S. Hellenbrand, Paola E.J. van der Meijden, Tilman M. Hackeng, Hugo ten Cate, Magdolna Nagy, Yvonne M.C. Henskens, Henri M.H. Spronk
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 24, 2026, 02:59Melissa Hollo: Making Early Anemia Detection the Standard of Care
-
Jun 24, 2026, 02:51Bruno Pougault: The Thin Line Between Bleeding and Clotting
-
Jun 23, 2026, 23:30Shunsuke Iwano: PMDA Introduces Greater Flexibility for Pediatric Factor VIII and IX Development in Japan
-
Jun 23, 2026, 23:05Rounak Dubey: ISBT Academy Session on Agentic AI
-
Jun 23, 2026, 22:59Mohammed Maher Babiker: When ‘Low Platelets’ aren’t Really Low
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025
-
Jun 23, 2026, 22:03Erin VanDyke: A Journey Through VTE Leadership and Healthcare Transformation